A simple and rapid extraction of 11-dehydro-thromboxane B2.
スポンサーリンク
概要
- 論文の詳細を見る
Quantitative analysis of thromboxane (TX) levels <I>in vivo</I> is a useful approach to clerify clinical feature of cardiovascular disease. TXA<SUB>2</SUB> is metabolized to TXB<SUB>2</SUB> at nonenzymatic. Consequently plasma TXB<SUB>2</SUB> level is fluctuated by TXA<SUB>2</SUB> which was produced from platelets during blood collection. 11-dehydro-thromboxane B<SUB>2</SUB> (11 DT) is a major metabolite of TXB<SUB>2</SUB> and not producedby the stimulation of platelets during blood collection.<BR>We studied a simple and rapid extraction method for 11 DT. 11 DT was extracted from sample by the addition of octadecylsilyl silica powder (80 mg/m<I>l</I>) suspended in 40% aqueous EtOH followed by the fractionation using silica open minicolumn BOND ELUT Si (Analytichem International, Inc., Harbor City, USA) solutions in three different composition of acetonitrile, chloroform and acetic acid were used as eluents. These fractions were quantitated by radioimmunoassay (NEN, Boston USA) .<BR>11 DT was recovered 76.1±2.3% (n=10) as closed form using the both of open and closed form of [<SUP>3</SUP>H] -11 DT as tracer. Concentrated plasma 11 DT obtained by this method in normal subject was less than 5.2 pg/m<I>l</I> (n=130, male; n=64 age 1948, female; n=66 age 18-48) . There was no sexual difference in plasma 11 DT level by this method. Plasma 11 DT levelwas not so high as that of TXB<SUB>2</SUB> which was directly influenced by the platelet release during blood collection. Serum 11 DT level was 2, 400±500 pg/m<I>l</I> (n=10) which is higher than that in plasma (7.1±1.9 pg/m<I>l</I>) .<BR>In conclusion, the technical advantages of this method can be summarized into two major points, simplicity and requiring small volume of sample.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発